Cyprus vs Iraq: HIV/AIDS deaths averted by antiretroviral therapy
Cyprus
64 deaths
in 2021
Iraq
77.64 deaths
in 2024
Cyprus rank
131st
Iraq rank
130th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Cyprus
- Iraq
How they compare
Iraq currently reports 77.64 deaths against 64 deaths in Cyprus, a difference of 13.64 deaths.
That makes Iraq's figure about 1.2 times Cyprus's.
The two have swapped places 3 times across 32 shared years of data; in 1990 it was Iraq ahead.
Cyprus ranks 131st and Iraq ranks 130th of 157 countries.
Across the 4 decades both report, Cyprus averaged higher in 2 and Iraq in 1.
Head to head by decade
| Decade | Cyprus | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 11.5 deaths | 12.75 deaths | 1.25 deaths | Iraq |
| 2010s | 42.1 deaths | 17.01 deaths | 25.09 deaths | Cyprus |
| 2020s | 63.5 deaths | 40 deaths | 23.5 deaths | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Cyprus or Iraq?
- Iraq, at 77.64 deaths against 64 deaths in Cyprus as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Cyprus and Iraq?
- 13.64 deaths, with Iraq ahead.
- How many years of comparable data are there for Cyprus and Iraq?
- 32 years are reported by both, from 1990 to 2021.
- How do Cyprus and Iraq rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Cyprus ranks 131st and Iraq ranks 130th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.